Health
Pet medication for deadly cat illness soon to be available in US: 'Huge triumph'
Many cat owners are rejoicing at the news that a drug used to treat an otherwise fatal illness for cats will be available in the United States as of June 1.
“Stokes Pharmacy has formed an exclusive partnership with the Bova Group to offer a U.S.-made compounded oral treatment for feline infectious peritonitis (FIP),” according to a statement from Stokes Pharmacy, a New Jersey-based compounding pharmacy.
Bova, a veterinary pharmaceuticals company based in the U.K. and Australia, began selling GS-441524, a drug compound to treat FIP, in 2021 — but the drug was not available for sale in the United States.
‘KITTENS’ DROPPED OFF AT ARIZONA HUMANE SOCIETY TURNED OUT TO BE SOMETHING ELSE
“This treatment is supported by Bova’s unique drug formula, which has been used in clinical research studies across the globe and is currently in use in the U.K. and Australia,” said Stokes.
Fox News Digital reached out to Stokes Pharmacy for further comment.
A drug that has been used in other countries to successfully treat FIP – an illness that kills cats unless treated – is now available in the United States. (iStock)
In a May 10 statement, the U.S. Food and Drug Administration (FDA) said there are “certain conditions where the agency does not intend to take enforcement actions for compounded products for use in animals,” and that the drugs are still not technically FDA-approved.
FIP is a “viral disease of cats caused by certain strains of a virus called the feline coronavirus,” according to the website for Cornell University’s Feline Health Center.
‘DEEPLY DEPRESSED’ MARYLAND SHELTER CAT GOES VIRAL AFTER ADOPTION PLEA
While most feline coronaviruses are relatively harmless and resolve on their own, the virus sometimes mutates into what is known as FIP.
“Once a cat develops clinical FIP, the disease is usually progressive and almost always fatal,” the Cornell website states.
Until now, U.S. cat owners have had to turn to the “black market” to obtain a drug that was not yet approved in this country.
While most feline coronaviruses are relatively harmless and resolve on their own, the virus sometimes mutates into what is known as FIP. (iStock)
FIP Warriors, a group founded in March 2019 that helps connect cat owners with medications needed to treat their cats, told Fox News Digital that they are “cautiously optimistic” at the news that veterinarians will be able to prescribe treatment for cats with FIP.
Still, the group noted, “We have very little factual information at this time and eagerly await more details from Bova and Stokes to become available. We are in direct contact with Bova and will be sharing all updates we receive with the entire FIP Warriors community.”
CAT ADOPTION AD GOES VIRAL FOR ITS REFRESHING HONESTY: ‘SHE WILL OWN YOU, YOUR HOUSE, YOUR BELONGINGS’
“Our sincere hope is that a safe, affordable and easily accessible medication option will help treat and cure as many FIP cats as possible and that this is a positive first step toward that goal,” the group added.
“We will continue our diligent work to educate both veterinarians and cat parents as the FIP landscape evolves.”
“Within 48 hours, I could see that my cat was starting to feel better, and within a week she was back to normal.”
One of the cat owners helped by the FIP Warriors organization told Fox News Digital about what she went through to save her cat.
Jessica Guyette, a resident of Washington, D.C., told Fox News Digital that she returned home from a trip to discover that one of her two cats had lost a significant amount of weight and was acting strangely.
Jessica Guyette of Washington, D.C., successfully treated her cat’s FIP with a drug regimen not yet legal in the United States. Above is her cat, pictured while sick, left, and after she was cured, right. (Jessica Guyette)
After several vet visits, Guyette was informed that her cat had FIP — and that there was nothing legally that could be done.
A veterinarian “secretly suggested” that she turn to online groups to acquire the drugs that might save her cat, which is what led her to FIP Warriors.
“At this point, there were no other options,” she said. “She was still losing weight, very lethargic, and I could tell that she was dying.”
NEW YORK CAT RESCUED FROM HOARDING SITUATION IS NOW AVAILABLE FOR ADOPTION
Guyette, who works as a researcher for the National Institutes of Health, said she and her cat saw quick results.
“Within 48 hours, I could see that my cat was starting to feel better, and within a week she was back to normal,” she said — describing the overall experience of trying to save her as “terrifying.”
She added, “I brought her in [to the vet] every month to run blood tests and the vet was astonished to find that she was back to normal, when she had been on the brink of death.”
Hannah Shaw, known on YouTube as the “Kitten Lady,” runs a nonprofit to rescue kittens and to educate others on how to care for vulnerable kittens. (Andrew Marttila)
Activist and author Hannah Shaw, founder of the nonprofit organization Kitten Lady, also treated her own cat, Coco, for FIP using black market drugs and documented the process on her YouTube channel, “Kitten Lady.”
“It is a huge triumph that FIP — which has been considered a fatal disease for so long — is now able to be legally treated by veterinarians,” the California-based Shaw told Fox News Digital via email.
“This moment is the culmination of years of research, advocacy and activism from a movement that is sick of seeing cats die due to lacking access to lifesaving treatment.”
Shaw’s latest book, “Cats of the World,” will be released in October.
In the past, when veterinarians were told to “remain hands-off” when advising cat owners about treating FIP, it was “confusing and isolating for people who discover that their cats have been diagnosed with the disease,” she said.
Even more frustrating, said Shaw, was how “animal advocates have been successfully treating cats for FIP for a number of years, but navigating that care has been incredibly complicated for the average cat guardian.”
Coco, one of Shaw’s cats, developed FIP while undergoing chemotherapy, she told Fox News Digital.
It was only due to “total strangers on the internet” that Shaw was able to obtain the medication and successfully treat Coco, she said.
“It is a huge triumph that FIP — which has been considered a fatal disease for so long — is now able to be legally treated by veterinarians,” an activist told Fox News Digital. (iStock)
“GS-441524 completely cured her of FIP, and thanks to the drug, I got another amazing two years with her,” she said.
The ability for veterinarians to discuss FIP treatment with cat owners and for the drugs to be obtained through legal means is a “massive win,” Shaw said, “and is going to help so many people save their cats’ lives.”
“This moment is the culmination of years of research, advocacy and activism from a movement that is sick of seeing cats die due to lacking access to lifesaving treatment, and it’s a huge cause for celebration,” she added.
For more Lifestyle articles, visit www.foxnews.com/lifestyle.
NEWYou can now listen to Fox News articles!
The Murdoch Children’s Research Institute (MCRI) in Australia will receive a $5 million federal grant to launch a pioneering research team for children’s health.
The grant was announced at MCRI’s 40th anniversary gala in Melbourne on Saturday night.
“For 40 years, MCRI has been a global leader in children’s health research,” Prime Minister Anthony Albanese told guests at the gala, which was attended by 300 of Australia’s most esteemed medical experts, political leaders, philanthropists and sports luminaries.
INTERNATIONAL EFFORT SEEKS NEW TREATMENTS FOR PEDIATRIC HEART DISEASE
“My government is proud to partner with MCRI, so our world-leading researchers have the best opportunities to support healthier childhoods for Australians now and into the future.”
The $5 million will directly support medical research aimed at preventing numerous childhood conditions, including obesity, heart disease, mental health issues and disabilities.
Australian Prime Minister Anthony Albanese speaks at the MCRI gala. (Penny Stephens/Murdoch Children’s Research Institute)
Also announced at the gala, a lead donation from Sarah and Lachlan Murdoch will launch the Horizon Fund — a permanent endowment for MCRI aimed at funding long-term children’s health research and future medical breakthroughs.
THE TEEN ANXIETY EPIDEMIC IN THE US AND AUSTRALIA — AND WHAT TO DO ABOUT IT
The goal is for the fund to raise between $50 million and $100 million in its first year and to reach $200 million within five years.
The fund is designed to back researchers’ immediate priorities while safeguarding long-term capital for future medical breakthroughs in children’s health.
Pictured above, Sarah Murdoch (MCRI co-chair); Jodie Haydon (wife of Prime Minister Albanese); Australian Prime Minister Anthony Albanese; Kathryn North (MCRI director); and Patrick Houlihan (MCRI chair). (Christopher Hopkins/Murdoch Children’s Research Institute)
In 2020, the Murdochs donated $5 million to establish a perpetual fellowship supporting leading researchers in fields including stem cell technology and genomic precision medicine.
Co-founded in 1986 by philanthropist and child health advocate Dame Elisabeth Murdoch and pediatrician and genetics pioneer Professor David Danks, MCRI comprises 1,800 scientists, researchers and clinicians.
CLICK HERE FOR MORE HEALTH STORIES
“Dame Elisabeth’s leadership, along with her values, shaped both the direction and the ethos of the Institute we were to become – for all children to live a healthy and fulfilled life,” said Sarah Murdoch, who is Dame Elisabeth Murdoch’s granddaughter-in-law and MCRI’s global ambassador and board co-chair.
Sarah Murdoch (MCRI co-chair) is pictured with Kathryn North (MCRI director) at the Murdoch Children’s Research Institute 40th Anniversary Gala at the State Library Melbourne. (Penny Stephens/Murdoch Children’s Research Institute)
“With the generosity of a remarkable group of founding donors alongside the Murdoch family – Sir Jack Brockhoff, the Miller family, and The Scobie and Claire Mackinnon Trust – the foundations were laid for an Institute designed to bring our brightest minds, to serve all children, not only in that moment, but for generations to come,” Ms. Murdoch added.
“I see what is possible when foresight, science, commitment, collaboration and heartfelt generosity come together,” she emphasized.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Because behind every breakthrough is a child — a family desperate for answers. A future changed because of the commitment by so many.”
MCRI Director Kathryn North expressed appreciation at the gala to the prime minister for the $5 million grant.
“From the beginning, MCRI has been guided by a simple but powerful purpose: to give all children the opportunity to live a healthy and fulfilled life,” said the MCRI director. (MCRI)
“From the beginning, MCRI has been guided by a simple but powerful purpose: to give all children the opportunity to live a healthy and fulfilled life,” North said.
“It reflects a belief that good health is the foundation for a full life, and that opportunity should never be limited by circumstance.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Professor North mentioned the Institute’s focus on developing therapies for previously incurable diseases.
“We are harnessing the power of human stem cell technologies to grow heart patches, functional mini kidneys, blood and immune cells … to better understand disease, and to develop regenerative therapies using a patient’s own stem cells to replace organ transplants and the risk of rejection,” she said.
The Institute’s next challenge is to address chronic conditions like asthma, obesity, allergies and mental health conditions that can persist for decades. (iStock)
The Institute’s next challenge, North said, is to address chronic conditions like asthma, obesity, allergies and mental health conditions that can persist for decades.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“These are big problems that will require significant and ongoing support,” she said. “Through our work globally, we are helping communities raise their expectations to both deliver and receive the sort of healthcare we take for granted.”
“Our ambition now is to translate these partnerships into population-scale solutions that improve the lives of millions of children worldwide,” North added. “This is not simply the next chapter for MCRI – it is the work of building the future of children’s health.”
FDA fast-tracks pancreatic cancer drug daraxonrasib
Family and emergency medicine physician Dr. Janette Nesheiwat discusses how artificial intelligence could help detect pancreatic cancer earlier and the FDA fast-tracking the drug daraxonrasib on ‘Fox Report.’
NEWYou can now listen to Fox News articles!
A new drug for pancreatic cancer is showing promise in early testing.
Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical trial — the first time it was tested in people — to evaluate both its safety and effectiveness.
The clinical trial, led by the Dana-Farber Cancer Institute and published in The New England Journal of Medicine, tested the drug in 168 patients with advanced pancreatic cancer whose tumors had mutations in the RAS gene. All study participants had previously received at least one chemotherapy treatment.
6 THINGS TO KNOW ABOUT PANCREATIC CANCER AFTER FORMER SENATOR’S DIAGNOSIS
The drug is designed to block multiple active cancer signals that help tumor cells grow. This is especially important because more than 90% of pancreatic cancers carry these harmful mutations, researchers said.
Existing and older drugs that target RAS mutations only work on certain types that are uncommon in pancreatic cancer, such as KRAS mutations.
Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical trial to evaluate its safety and effectiveness. (iStock)
At the 300-milligram dose — the amount that will be used in larger phase 3 trials — about 30% of patients saw a positive response, researchers noted. Overall, about 90% of patients had their cancer either shrink or stop getting worse.
DEADLY CANCER TYPE LINKED TO OBESITY AND HIGH STRESS LEVELS
There were some side effects reported — most commonly rash, mouth inflammation, nausea and diarrhea.
Lead investigator Dr. Brian Wolpin, director of the Hale Family Center for Pancreatic Cancer Research at Dana-Farber, commented in a press release statement that this development could change the future of cancer care.
About 90% of patients treated with the drug experienced disease control, meaning their cancer was reduced or stabilized. (iStock)
“If supported by data from future clinical trials, daraxonrasib would be a targeted therapy relevant to nearly all patients with advanced pancreatic cancer,” he said.
RISK OF DEADLY CANCER TRIPLES WITH HIDDEN MOUTH BACTERIA, STUDY FINDS
“This trial provides the first published data showing the safety and broad activity of a RAS(ON) multi-selective inhibitor in pancreatic cancer,” Wolpin went on. “If it proves effective in larger clinical trials, it would signify a substantial shift in how this disease is treated.”
In an interview with Fox News Digital, the researcher claimed that daraxonrasib represents “one of the most promising therapy advances we’ve seen in pancreatic cancer.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
This is especially significant since pancreatic cancer has had “very few effective therapies” in the past, Wolpin noted.
“The study also showed disease control in approximately 90% of patients with metastatic pancreatic cancer, which is extremely exciting,” he added.
The study does not prove daraxonrasib is superior to standard treatment of chemotherapy, researchers noted. (iStock)
Wolpin noted that while side effects were common, most patients were able to tolerate treatment with “supportive care measures, and very few patients needed to stop therapy due to side effects.”
As this was a phase 1/2 study, it does not “definitively prove” the superiority of daraxonrasib compared to chemotherapy, Wolpin added.
CLICK HERE FOR MORE HEALTH STORIES
“The study did not include a randomized control arm that directly compared daraxonrasib with chemotherapy,” he said. “That being said, the results for daraxonrasib looked substantially better than what we have seen in prior clinical trials of chemotherapy in patients with previously treated metastatic pancreatic cancer.”
It also remains unclear how the drug may perform earlier in the disease, as the trial included patients who had already received prior treatments.
“Additional research is needed to determine how best to sequence or combine therapies to provide the most durable responses and cures,” the lead investigaror sid. (iStock)
For patients and families affected by pancreatic cancer, Wolpin noted that daraxonrasib signals “real momentum” toward effective treatments, but it is still investigational and is not a cure.
“Pancreatic cancer remains a challenging disease, and additional research is needed to determine how best to sequence or combine therapies to provide the most durable responses and cures,” he said.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Brian Slomovitz, director of gynecologic oncology and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, applauded this development in a separate interview with Fox News Digital.
“We are anxiously awaiting the upcoming plenary presentation of RASolute 302 at the ASCO meeting later this month,” said the expert, who was not involved in the study. “Greater than 90% of pancreatic cancers have activation of kRAS, which is a major factor in the development and progression of these cancers.”
“Doubling the survival time in pretreated patients is unprecedented.”
“If the full dataset results that will be reported later this month confirm what was earlier released, I believe this will be one of the most important breakthroughs in all solid tumors,” Slomovitz went on. “Doubling the survival time in pretreated patients is unprecedented.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The doctor added that the “magnitude of benefit” could “reshape the treatment landscape” and “establish a new standard of care.”
“We will need to evaluate the full dataset for efficacy and safety,” Slomovitz added. “I am more than cautiously optimistic, and I am truly excited for our patients and their families that suffer from this dreadful disease.”
NEWYou can now listen to Fox News articles!
People who regularly visit museums or participate in creative activities may be aging more slowly on a biological level, according to a new study from the United Kingdom.
Researchers from University College London analyzed data from more than 3,500 adults and found that people who frequently engaged in arts and cultural activities showed signs of slower biological aging in several DNA-based measurements.
The findings were published in the journal Innovation in Aging.
CREATIVE HOBBIES KEEP THE BRAIN YOUNG, STUDY FINDS — HERE ARE THE BEST ONES TO PURSUE
The study examined activities including painting, photography, dancing, singing, visiting museums and attending cultural events or historic sites.
People who frequently visit museums or engage in artistic activities may experience slower biological aging. (iStock)
Researchers compared participation in those activities with “epigenetic clocks,” scientific tools that examine chemical changes in DNA over time.
Adults who participated more often, and in a wider variety of activities, tended to show slower aging scores compared to people who rarely engaged in arts or cultural experiences.
ANTI-AGING BENEFITS LINKED TO ONE SURPRISING HEALTH HABIT
The association appeared even stronger among adults over age 40.
Researchers also noted that the effect sizes were comparable to those linked to physical activity, one of the most widely studied behaviors associated with healthy aging.
The study found that adults who engaged more often in arts and cultural activities showed slower biological aging. (iStock)
Jessica Mack, a health and wellness expert and founder of The Functional Consulting Group who was not involved in the study, said the findings reflect a growing understanding that health is influenced by more than exercise and nutrition alone.
“Arts and cultural engagement may be associated with slower epigenetic aging, with effects comparable in some measures to physical activity,” Mack told Fox News Digital.
She said activities such as visiting museums and engaging with music or art may help reduce stress, improve emotional regulation and increase social connection.
Experts say these activities may reduce stress, improve emotional regulation, and strengthen social connections. (iStock)
“These are not ‘extra’ lifestyle activities,” Mack said. “They may be deeply connected to how the body manages inflammation, stress hormones, mood and overall resilience.”
CLICK HERE FOR MORE LIFESTYLE STORIES
Mack added that people experiencing stress, social isolation, retirement or caregiving responsibilities may especially benefit from meaningful cultural engagement.
Experts cautioned, however, that the study does not prove arts engagement directly slows aging.
“This is an observational study, not an experiment,” Professor Steve Horvath of UCLA, a longevity researcher and pioneer in epigenetic aging research who was not involved in the study, told Fox News Digital.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“So when researchers find that the people who go to museums have younger epigenetic age, we cannot tell whether the museum visits slowed their aging, or whether their slower aging is what allowed them to keep visiting museums,” he said.
While the findings suggest a link, experts caution that the study cannot prove arts and cultural activities directly slow aging. (iStock)
Horvath said both explanations may be true to some degree, though he described the research as “methodologically careful” and worthy of further study.
The findings remained consistent even after accounting for factors such as smoking, income, body weight and other lifestyle habits.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
He added that regardless of whether arts engagement is directly slowing biological aging, staying socially and mentally active is still associated with healthier aging overall.
“The prescription is the same,” he said. “Keep going.”
-
Nevada3 minutes agoNevada workers fear homelessness as housing, jobs vanish before July deadline | Fox News Video
-
New Hampshire9 minutes agoOpinion: The nostalgia of a small town – Concord Monitor
-
New Jersey15 minutes agoNJ, NY governors cut World Cup transit costs. Where is host committee?
-
New Mexico21 minutes agoAre National Guard troops, emergency state funds effective in Rio Arriba County?
-
North Dakota33 minutes ago
Behind the Badge – Does Poaching Really Matter?
-
Ohio39 minutes agoWhere to find splash pads, pools in central Ohio during heat wave
-
Oklahoma45 minutes agoNewspaper Deletes Column Comparing the Oklahoma City Thunder to Israel
-
Oregon51 minutes ago
Oregon Lottery Powerball, Pick 4 results for May 18
